Demographic and clinical details for pneumothorax and coronavirus disease 2019
| Age years | |
| 21–30 | 1 (2) |
| 31–40 | 4 (7) |
| 41–50 | 10 (17) |
| 51–60 | 16 (27) |
| 61–70 | 14 (23) |
| 71–80 | 15 (25) |
| Female | 14 (23) |
| Side affected | |
| Right | 38 (63) |
| Left | 18 (30) |
| Bilateral | 4 (7) |
| Smoking status | |
| Never-smoker | 34 (57) |
| Current smoker | 3 (5) |
| Ex-smoker | 15 (25) |
| Unknown | 8 (13) |
| Respiratory comorbidities | |
| COPD | 6 (10) |
| Asthma | 10 (17) |
| Bronchiectasis | 2 (3) |
| Pneumothorax | 0 (0) |
| None | 43 (72) |
| Other comorbidities | |
| Systemic hypertension | 19 (32) |
| Hyperlipidaemia | 16 (27) |
| Atrial fibrillation | 3 (5) |
| Chronic kidney disease | 4 (7) |
| Type 2 diabetes mellitus | 10 (17) |
| Mode of breathing# | |
| Spontaneous | 20 (32) |
| CPAP/NIV | 3 (5) |
| Intubated and ventilated | 27 (44) |
| ECMO | 12 (20) |
| Mode of diagnosis# | |
| On admission | 9 (15) |
| Clinical change | 17 (27) |
| Incidental | 31 (50) |
| Clinical examination | 3 (5) |
| Unknown | 2 (3) |
| Management# | |
| Chest drain | 43 (69) |
| Chest drain then surgery | 1 (2) |
| Conservative | 15 (24) |
| Palliative | 3 (5) |
| Height¶ m | 1.72 (1.67–1.79) |
| BMI+ kg·m−2 | 27.0 (23.5–31.4) |
Data are presented as n (%) or median (interquartile range). CPAP: continuous positive airway pressure; NIV: noninvasive ventilation; ECMO: extracorporeal membrane oxygenation; BMI: body mass index. #: n=62 due to two patients with sequential pneumothoraces; ¶: n=52; +: n=53.